These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19325497

  • 1. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.
    Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M.
    J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):519-532. PubMed ID: 19325497
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M.
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
    Redden L, DelBello M, Wagner KD, Wilens TE, Malhotra S, Wozniak P, Vigna NV, Greco N, Kovacs X, Abi-Saab W, Saltarelli M, Depakote ER Pediatric Mania Group.
    J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG, Chou JC, Keck PE, Rhodes LJ, Swann AC, Hirschfeld RM, Wozniak PJ.
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [Abstract] [Full Text] [Related]

  • 9. An open-label trial of divalproex in children and adolescents with bipolar disorder.
    Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier JA, Wozniak P, Tracy K, Weller RA, Bowden C.
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1224-30. PubMed ID: 12364844
    [Abstract] [Full Text] [Related]

  • 10. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
    Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, Abi-Saab W, Saltarelli M, Depakote ER Mania Study Group.
    J Clin Psychiatry; 2006 Oct; 67(10):1501-10. PubMed ID: 17107240
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    Muzina DJ, Gao K, Kemp DE, Khalife S, Ganocy SJ, Chan PK, Serrano MB, Conroy CM, Calabrese JR.
    J Clin Psychiatry; 2011 Jun; 72(6):813-9. PubMed ID: 20816041
    [Abstract] [Full Text] [Related]

  • 13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Jun; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 14. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
    Ketter TA, Kalali AH, Weisler RH, SPD417 Study Group.
    J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE, Kowatch RA, Carmody T, Rush AJ.
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
    Pavuluri MN, Henry DB, Carbray JA, Naylor MW, Janicak PG.
    Bipolar Disord; 2005 Jun; 7(3):266-73. PubMed ID: 15898964
    [Abstract] [Full Text] [Related]

  • 20. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T, Vieta E, Liu S, Brecher M, Paulsson B, Trial 127 Investigators.
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.